Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | ||
| Net Income | -9,812 | -18,504 |
| Depreciation Amortization | 198 | 4,054 |
| Accounts payable and accrued liabilities | -483 | -56 |
| Other Working Capital | -478 | 1,130 |
| Other Operating Activity | 572 | 145 |
| Operating Cash Flow | $-10,003 | $-13,231 |
| Cash Flows From Investing Activities | ||
| Change In Deposits | 13,305 | -3,142 |
| PPE Investments | N/A | -7 |
| Purchase Of Investment | -11,667 | N/A |
| Investing Cash Flow | $1,638 | $-3,149 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | 37 | N/A |
| Other Financing Activity | 0 | 11,802 |
| Financing Cash Flow | $37 | $11,802 |
| Beginning Cash Position | 18,401 | 22,980 |
| End Cash Position | 10,073 | 18,401 |
| Net Cash Flow | $-8,328 | $-4,579 |
| Free Cash Flow | ||
| Operating Cash Flow | -10,003 | -13,231 |
| Capital Expenditure | N/A | -7 |
| Free Cash Flow | -10,003 | -13,238 |